CAMBRIDGE, Mass., Feb. 27, 2012 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat severe lipid disorders, announced that the Company will host a conference call and live audio webcast at 8:30 a.m. ET on Tuesday, March 6, 2012, to provide a business update and discuss its fourth-quarter and full-year 2011 financial and operational results.
